Seeking Alpha

Orexigen (OREX +17%) is another benificiary of Arena's (ARNA) good fortune today. Contrave is an...

Orexigen (OREX +17%) is another benificiary of Arena's (ARNA) good fortune today. Contrave is an investigational medication OREX has been working on that also focuses on the treatment of obesity, however it's still in the developmental stages.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs